Skip to main content
. 2017 Dec 13;7:17487. doi: 10.1038/s41598-017-17832-x

Figure 3.

Figure 3

HS-27 uptake is increased in aggressive breast tumor types in vivo. (a and b) Representative transmission and fluorescence images from tumor (MDA-MB-231 and BT-474) and non-tumor bearing window chambers in mice injected with either 20 mg/kg HS-27 (A) or 0.1 mL of 6 mM 2-NBDG (b). Transmission images are shown for reference of the tumor location. Scale bar is 2 mm. (c) Representative HS-2760 or 2-NDBG60/RD images for MDA-MB-231 and BT-474 window chambers. (d) Average HS-2760 and 2-NBDG60/RD were plotted against each other, revealing a strong correlation between the two endpoints (R2 = 0.96), red = MDA-MB-231, cyan = BT-474, and black = non-tumor window chambers. For HS-27 imaging, n = 3 for all groups. For 2-NBDG imaging, n = 3 for tumor groups, and n = 8 for normal groups.